Kolexia
Bedos Jean-Pierre
Médecine générale
Centre hospitalier de Versailles
Le Chesnay, France
116 Activités
34 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Pneumopathie infectieuse Maladie grave Arrêt cardiaque Sepsie État de mal épileptique Choc septique Infections communautaires Coma Hypothermie

Industries

Correvio
10 collaboration(s)
Dernière en 2021
Pfizer
9 collaboration(s)
Dernière en 2021
MSD
5 collaboration(s)
Dernière en 2022
Shionogi B.V
1 collaboration(s)
Dernière en 2020

Dernières activités

Real-life use of ceftobiprole for severe infections in a French intensive care unit.
Infectious diseases now   27 septembre 2023
PTH: Efficacy of a Preemptive Treatment by Ganciclovir or by Aciclovir in ICU Patients Requiring Prolonged Mechanical Ventilation and Presenting a Viral Replication (CMV and/or HSV) - Prospective, Randomized, Double-blinded Multicenter Trial
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   05 avril 2023
Clustering ICU patients with sepsis based on the patterns of their circulating biomarkers: A secondary analysis of the CAPTAIN prospective multicenter cohort study.
PloS one   27 octobre 2022
Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial.
Annals of intensive care   19 août 2022
Cerebrospinal fluid features in comatose survivors of cardiac arrest: A pilot study.
PloS one   26 juillet 2022
Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock
Proceedings of Reanimation 2022, the French Intensive Care Society International Congress   22 juin 2022
ENTRACT: Digestive ENdoscopy afTeR Out-of-hospitAl Cardiac arresT
Essai Clinique (Centre hospitalier de Versailles)   23 mai 2022
Ischemic injury of the upper gastrointestinal tract after out-of-hospital cardiac arrest: a prospective, multicenter study.
Critical care (London, England)   14 mars 2022
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Lancet (London, England)   29 novembre 2021
Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study.
Annals of intensive care   24 octobre 2021